Skip to main content
NEUROTECH INTERNATIONAL LIMITED logo

NEUROTECH INTERNATIONAL LIMITED — Investor Relations & Filings

Ticker · NTI ISIN · AU000000NTI9 ASX Professional, scientific and technical activities
Open in API
Filings indexed 667 across all filing types
Latest filing 2021-03-01 Capital/Financing Update
Country AU Australia
Listing ASX NTI

About NEUROTECH INTERNATIONAL LIMITED

https://neurotechinternational.com/

Neurotech International Limited is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for neurodevelopmental and neurological disorders. The company specializes in neuroprotective therapies, primarily targeting pediatric conditions with significant unmet medical needs, including Autism Spectrum Disorder (ASD), Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS), and Pediatric Acute-onset Neuropsychiatric Syndrome (PANS). Its lead drug candidate, NTI164, is a proprietary, broad-spectrum cannabinoid formulation derived from a unique cannabis strain. NTI164 is engineered to exert anti-inflammatory and neuroprotective effects by modulating neuroinflammatory pathways. The company conducts clinical trials to establish the safety and efficacy of its treatments, aiming to provide transformative behavioral and functional improvements for patients.

Recent filings

Filing Released Lang Actions
Proposed issue of Securities - NTI 5 pages 28.0KB
Capital/Financing Update Classification · 100% confidence The document is an announcement regarding a proposed issue of securities by Neurotech International Limited. It details the number of securities to be issued, the issue price, the proposed issue date, and other related information such as fees and approvals. The content focuses on the company's capital raising activity through a placement of shares. There are no financial statements or detailed financial performance data present, which rules out classifications like Annual Report (10-K) or Interim Report (IR). The document is not a report publication announcement or a regulatory filing in the form of certification or attestation. The primary subject is the update on the company's capital structure and fundraising activity, which fits the Capital/Financing Update (CAP) category.
2021-03-01 English
Proposed issue of Securities - NTI 5 pages 28.3KB
Capital/Financing Update Classification · 100% confidence The document is an announcement regarding a proposed issue of securities by Neurotech International Limited. It details the number of securities to be issued, the issue price, the underwriting arrangements, and other related information. There are no financial statements or comprehensive financial data presented, and the document is focused on informing about a capital raising event. This fits the definition of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising and capital structure changes.
2021-03-01 English
Proposed issue of Securities - NTI 6 pages 29.8KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Proposed issue of securities' and contains detailed information about a proposed placement or other type of securities issue by Neurotech International Limited. It includes specifics such as the number of securities, exercise price, expiry date, conditions for approval, and other details related to the issuance process. There is no indication of financial statements, earnings data, or management discussion. The content focuses entirely on the announcement of a new securities issuance, which aligns with the category for announcements regarding new share issues or capital changes. Therefore, the document fits the 'Share Issue/Capital Change' category (SHA). The document length and detail confirm it is not a brief announcement or a report publication notice but a full announcement of a capital change.
2021-03-01 English
Proposed issue of Securities - NTI 6 pages 29.8KB
Capital/Financing Update Classification · 100% confidence The document is an announcement from Neurotech International Limited regarding a proposed issue of securities, specifically options with details about exercise price, expiry date, and conditions for issuance. It includes information about approvals required, the nature of the securities, and the timetable for the issue. The content focuses on the details of a capital raising event through a placement or other type of issue. There are no financial statements or comprehensive financial performance data, so it is not an Annual Report or Interim Report. It is not a report publication announcement since the document itself contains substantive details about the proposed issue. The document fits the definition of a Capital/Financing Update, which covers updates on company fundraising and capital structure changes.
2021-03-01 English
Proposed issue of Securities - NTI 5 pages 27.4KB
Capital/Financing Update Classification · 95% confidence The document is titled 'Proposed issue of securities' and details a placement or other type of issue of securities by Neurotech International Limited. It includes specifics such as the number of securities to be issued, the issue date, and compliance with ASX listing rules. There is no financial performance data, earnings information, or management discussion. The content is focused on the announcement of a capital raising or securities issuance event. This matches the definition of a Capital/Financing Update (CAP). The document length is sufficient and contains substantive details about the proposed issue, not just a brief notice or link to a report, so it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS). Therefore, the correct classification is CAP with high confidence.
2021-03-01 English
Proposed issue of Securities - NTI 5 pages 27.5KB
Capital/Financing Update Classification · 100% confidence The document is an announcement regarding a proposed issue of securities by Neurotech International Limited. It details the number of securities to be issued, the type of securities, the proposed issue date, conditions including shareholder approval, and other related information. There is no financial performance data, management discussion, or detailed financial statements. The document is focused on informing about a capital raising or share issuance event. This fits the definition of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising or capital structure changes.
2021-03-01 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.